Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does the presence of hepatic steatosis influence the efficacy of antiviral treatment in patients with hepatitis C?

Nature Clinical Practice Gastroenterology & Hepatology volume 4, pages 548–549 (2007)Cite this article

boxed-textLok AS et al. (2007) Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial. Clin Gastroenterol Hepatol 5: 245–254

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Dore GJ et al. (2002) Is severe liver disease a common outcome for people with chronic hepatitis C? J Gastroenterol Hepatol 17: 423–430

    Article  Google Scholar 

  2. Lefkowitch JH et al. (1993) Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. Gastroenterology 104: 595–603

    Article  CAS  Google Scholar 

  3. Wang CS et al. (2007) Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study. Am J Epidemiol 166: 196–203

    Article  Google Scholar 

  4. Poynard T et al. (2003) Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C. Hepatology 38: 75–85

    Article  CAS  Google Scholar 

  5. Romero-Gomez M (2006) Insulin resistance and hepatitis C. World J Gastroenterol. 12: 7075–7080

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Jones, Nature Clinical Practice.

Author information

Author notes

  1. 2nd Medical Department, University Leipzig, Philipp Rosenthal Strasse 27, 04103 Leipzig, Germany hans.tillmann@medizin.uni-leipzig.de

Authors and Affiliations

  1. HL Tillmann is a Professor of Medicine at the University of Leipzig, Leipzig, Germany.,

    Hans L Tillmann

Authors
  1. Hans L Tillmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tillmann, H. Does the presence of hepatic steatosis influence the efficacy of antiviral treatment in patients with hepatitis C?. Nat Rev Gastroenterol Hepatol 4, 548–549 (2007). https://doi.org/10.1038/ncpgasthep0930

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep0930

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing